Literature DB >> 16024782

hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation.

Mary Lynch1, Li Chen, Michael J Ravitz, Sapna Mehtani, Kevin Korenblat, Michael J Pazin, Emmett V Schmidt.   

Abstract

Translation initiation factor eukaryotic translation initiation factor 4E (eIF4E) plays a key role in regulation of cellular proliferation. Its effects on the m7GpppN mRNA cap are critical because overexpression of eIF4E transforms cells, and eIF4E function is rate-limiting for G1 passage. Although we identified eIF4E as a c-Myc target, little else is known about its transcriptional regulation. Previously, we described an element at position -25 (TTACCCCCCCTT) that was critical for eIF4E promoter function. Here we report that this sequence (named 4EBE, for eIF4E basal element) functions as a basal promoter element that binds hnRNP K. The 4EBE is sufficient to replace TATA sequences in a heterologous reporter construct. Interactions between 4EBE and upstream activator sites are position, distance, and sequence dependent. Using DNA affinity chromatography, we identified hnRNP K as a 4EBE-binding protein. Chromatin immunoprecipitation, siRNA interference, and hnRNP K overexpression demonstrate that hnRNP K can regulate eIF4E mRNA. Moreover, hnRNP K increased translation initiation, increased cell division, and promoted neoplastic transformation in an eIF4E-dependent manner. hnRNP K binds the TATA-binding protein, explaining how the 4EBE might replace TATA in the eIF4E promoter. hnRNP K is an unusually diverse regulator of multiple steps in growth regulation because it also directly regulates c-myc transcription, mRNA export, splicing, and translation initiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024782      PMCID: PMC1190351          DOI: 10.1128/MCB.25.15.6436-6453.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  106 in total

1.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.

Authors:  M K Mateyak; A J Obaya; S Adachi; J M Sedivy
Journal:  Cell Growth Differ       Date:  1997-10

2.  Molecular cloning and expression of the mouse translation initiation factor eIF-1A.

Authors:  W Davis; R M Schultz
Journal:  Nucleic Acids Res       Date:  1998-10-15       Impact factor: 16.971

3.  The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein.

Authors:  W M Michael; P S Eder; G Dreyfuss
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

4.  Genomic cloning and characterization of the human eukaryotic initiation factor-2beta promoter.

Authors:  J A Chiorini; S Miyamoto; S J Harkin; B Safer
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

5.  Detection of eIF4E gene amplification in breast cancer by competitive PCR.

Authors:  D L Sorrells; D R Black; C Meschonat; R Rhoads; A De Benedetti; M Gao; B J Williams; B D Li
Journal:  Ann Surg Oncol       Date:  1998 Apr-May       Impact factor: 5.344

6.  Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma.

Authors:  B D Li; L Liu; M Dawson; A De Benedetti
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

7.  Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1.

Authors:  A L Roy; H Du; P D Gregor; C D Novina; E Martinez; R G Roeder
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

8.  Transcription properties of a cell type-specific TATA-binding protein, TRF.

Authors:  S K Hansen; S Takada; R H Jacobson; J T Lis; R Tjian
Journal:  Cell       Date:  1997-10-03       Impact factor: 41.582

9.  Novel regulatory factors interacting with the promoter of the gene encoding the mRNA cap binding protein (eIF4E) and their function in growth regulation.

Authors:  K A Johnston; M Polymenis; S Wang; J Branda; E V Schmidt
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

10.  Differential effects of heterogeneous nuclear ribonucleoprotein K on Sp1- and Sp3-mediated transcriptional activation of a neuronal nicotinic acetylcholine receptor promoter.

Authors:  Q Du; I N Melnikova; P D Gardner
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

View more
  55 in total

1.  Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site.

Authors:  Dörte Adolph; Nadine Flach; Katharina Mueller; Dirk H Ostareck; Antje Ostareck-Lederer
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

2.  Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.

Authors:  David Luyimbazi; Argun Akcakanat; Priscilla F McAuliffe; Li Zhang; Gopal Singh; Ana Maria Gonzalez-Angulo; Huiqin Chen; Kim-Anh Do; Yuhuan Zheng; Mien-Chie Hung; Gordon B Mills; Funda Meric-Bernstam
Journal:  Mol Cancer Ther       Date:  2010-09-28       Impact factor: 6.261

3.  The connectivity map links iron regulatory protein-1-mediated inhibition of hypoxia-inducible factor-2a translation to the anti-inflammatory 15-deoxy-delta12,14-prostaglandin J2.

Authors:  Michael Zimmer; Justin Lamb; Benjamin L Ebert; Mary Lynch; Christopher Neil; Emmett Schmidt; Todd R Golub; Othon Iliopoulos
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

4.  Transcriptional regulation of heterogeneous nuclear ribonucleoprotein K gene expression.

Authors:  Liqing He; Xiaochang Xue; Zhengjun Wang; Entai Hou; Yong Liu; Mingyu Liang; Yingqi Zhang; Zhongmin Tian
Journal:  Biochimie       Date:  2014-12-10       Impact factor: 4.079

Review 5.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

6.  Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.

Authors:  Renyuan Zhou; Reneé Shanas; Mark A Nelson; Achyut Bhattacharyya; Jiaqi Shi
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

7.  Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10.

Authors:  Misti C White; Rui Gao; Weidong Xu; Santi M Mandal; Jung G Lim; Tapas K Hazra; Maki Wakamiya; Sharon F Edwards; Salmo Raskin; Hélio A G Teive; Huda Y Zoghbi; Partha S Sarkar; Tetsuo Ashizawa
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

Review 8.  Insights into the biology of IRES elements through riboproteomic approaches.

Authors:  Almudena Pacheco; Encarnacion Martinez-Salas
Journal:  J Biomed Biotechnol       Date:  2010-02-02

Review 9.  Poly(C)-binding proteins as transcriptional regulators of gene expression.

Authors:  Hack Sun Choi; Cheol Kyu Hwang; Kyu Young Song; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  Biochem Biophys Res Commun       Date:  2009-01-27       Impact factor: 3.575

10.  Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.

Authors:  P Barboro; E Repaci; A Rubagotti; S Salvi; S Boccardo; B Spina; M Truini; C Introini; P Puppo; N Ferrari; G Carmignani; F Boccardo; C Balbi
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.